G6PD and ovarian carcinoma: The study demonstrated that it could not only inhibit G6PD significantly in a non-competitive and reversible way but also suppress the proliferation of ovarian cancer cells, which suggests that Wedelolactone affects the proliferation of ovarian cancer cells partly through blocking the enzyme activity of G6PD [88].